We are live on ! Find out more
PSTV icon

Plus Therapeutics

3 hedge funds and large institutions have $35.4M invested in Plus Therapeutics in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $33.4M → $35.4M (+$2.02M)

0% more funds holding

Funds holding: 33 (0)

65% less call options, than puts

Call options by funds: $178K | Put options by funds: $511K

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$178K
Puts
$511K
Net Calls
-$333K
Net Calls Change
+$45K

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
TA
26
Teachers Advisors
New York
$226K
Charles Schwab
27
Charles Schwab
California
$201K
Group One Trading
28
Group One Trading
Illinois
$198K
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$166K
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$162K
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$162K
Millennium Management
32
Millennium Management
New York
$140K
NFG
33
Noven Financial Group
Colorado
$136K
AIG
34
American International Group
New York
$132K
NFA
35
Nationwide Fund Advisors
Ohio
$128K
Janney Montgomery Scott
36
Janney Montgomery Scott
Pennsylvania
$126K
Jane Street
37
Jane Street
New York
$121K
Renaissance Technologies
38
Renaissance Technologies
New York
$119K
State Board of Administration of Florida Retirement System
39
State Board of Administration of Florida Retirement System
Florida
$116K
LMF
40
LMR Master Fund
Cayman Islands
$115K
BA
41
BlackRock Advisors
Delaware
$113K
DekaBank Deutsche Girozentrale
42
DekaBank Deutsche Girozentrale
Germany
$109K
PP
43
Paloma Partners
Connecticut
$104K
CS
44
Credit Suisse
Switzerland
$101K
EEG
45
E.E. Geduld
$90K
Citigroup
46
Citigroup
New York
$86K
TDC
47
Thompson Davis & Co
Virginia
$86K
WAM
48
Wolverine Asset Management
Illinois
$86K
Commonwealth Equity Services
49
Commonwealth Equity Services
Massachusetts
$84K
GC
50
Guggenheim Capital
Illinois
$84K

PSTV Hedge Fund Activity: Q4 2013 in Review

3 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2013, worth a combined $35.4M — up 6.1% from $33.4M a quarter earlier.

Fund positioning in PSTV was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Jennison Associates, cutting an estimated $847K.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $35.4M of Plus Therapeutics stock for Q4 2013, up 6.1% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q4 2013 and 0 closed out.
  • The largest Plus Therapeutics seller in Q4 2013 was Jennison Associates, an estimated $847K sold.

Based on aggregated 13F filings for Q4 2013.